Which type of type 3 diabetes is caused by steroid (glucocorticoid) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Steroid-Induced Diabetes is NOT Type 3 Diabetes

Steroid-induced hyperglycemia or steroid-induced diabetes is a distinct entity caused by glucocorticoid therapy and is NOT classified as type 3 diabetes. Type 3 diabetes refers to pancreatogenic diabetes resulting from exocrine pancreatic disease (post-pancreatitis, pancreatic surgery, tumors, cystic fibrosis, hemochromatosis), not steroid-induced hyperglycemia 1.

Understanding the Classification

The term "type 3 diabetes" encompasses specific forms of diabetes due to diseases of the exocrine pancreas. Steroid-induced diabetes falls under a separate category of drug-induced diabetes, which includes hyperglycemia caused by:

  • Glucocorticoids
  • Immune checkpoint inhibitors
  • Calcineurin inhibitors
  • Antipsychotics
  • HAART therapy 1

Why This Distinction Matters Clinically

Steroid-Induced Diabetes Characteristics:

  • Reversible when steroids are discontinued or tapered 2
  • Distinct glucose pattern: afternoon/evening postprandial hyperglycemia with often normal fasting glucose 3, 4
  • Peak hyperglycemia occurs 7-9 hours after dexamethasone and 8 hours after prednisone 2
  • Requires insulin adjustment matched to steroid pharmacokinetics 2

Type 3c (Pancreatogenic) Diabetes Characteristics:

  • Results from structural pancreatic damage 2
  • Often irreversible depending on extent of pancreatic injury
  • May not require insulin initially if residual beta-cell function exists 2
  • Associated with exocrine pancreatic insufficiency 1

Diagnostic Criteria for Steroid-Induced Diabetes

Diagnosis requires:

  • Two abnormal glucose tests (random BGL ≥11.1 mmol/L on different occasions and/or HbA1c ≥6.5%)
  • Active corticosteroid use
  • No previous diabetes history 2

Management Algorithm

For mild hyperglycemia (BGL 11-15 mmol/L):

  • Gliclazide for isolated daytime hyperglycemia
  • Add metformin if renal/hepatic function preserved 2

For moderate hyperglycemia:

  • NPH insulin given with morning steroid dose (matches the 8-hour peak) 5, 6
  • Dose: 0.3-0.5 units/kg initially 2

For severe hyperglycemia (BGL >15 mmol/L or >20 mmol/L with symptoms):

  • Basal-bolus insulin regimen
  • 50% long-acting (glargine), 50% rapid-acting (with meals) 2
  • Alternative: Mixed insulin (Novomix 30) for patients unable to manage multiple injections 2

Critical Pitfall

When steroids are tapered or discontinued, insulin requirements drop precipitously—hypoglycemia risk is substantial 7. Adjust diabetes medications immediately when steroid dose changes 2.

References

3
Research

[Glucocorticoid-induced diabetes].

Ugeskrift for laeger, 2026

6
Guideline

glucocorticoid-induced hyperglycemia including dexamethasone-associated hyperglycemia in covid-19 infection: a systematic review.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Related Questions

A patient with headache, fever up to 40 °C, nausea, sinus congestion, steroid‑induced diabetes requiring insulin, tachycardia, respiratory rate 18/min, blood pressure 110/70 mmHg, no papilledema, Glasgow coma scale 15, no focal neurologic deficits, leukocytosis of 15,000 cells/µL, and a normal basic metabolic panel—what is the next best step in management?
For a patient on methylprednisolone 1000 mg and NPH insulin 90 units administered at 10 am, with an insulin sensitivity factor of 10, a blood glucose of 363 mg/dL at 10 am, who received a correction bolus of 22 units of Novolog (insulin aspart) and had a blood glucose of 227 mg/dL at 2 pm, what should the NPH insulin dose be?
What should the morning (8 am) NPH insulin dose, the evening (8 pm) NPH insulin dose, the insulin‑to‑carbohydrate ratio, and the insulin sensitivity factor be for a 56‑year‑old female with type 2 diabetes, weight 81 kg, receiving dexamethasone 12 mg at 20:00 and methylprednisolone 81.25 mg at 20:00, currently on 8 U NPH at 08:00 with an insulin sensitivity factor of 50 mg/dL per unit and an insulin‑to‑carbohydrate ratio of 20 g per unit?
In a 62-year-old female with type 2 diabetes, weight 44.6 kg, receiving continuous tube feeding delivering 149 g carbohydrate per day and prednisone 30 mg at 8 am, currently on NPH insulin 35 U at 8 am and 4 U at 8 pm with an insulin-to-carbohydrate ratio of 12 g per unit and an insulin sensitivity factor of 25 mg/dL per unit, what should the morning and evening NPH doses, insulin sensitivity factor, and insulin-to-carbohydrate ratio be?
For a 59‑year‑old male weighing 123 kg with type 2 diabetes and normal renal function, who is currently on U‑500 regular insulin (115 U before breakfast, 115 U before lunch, 50 U before dinner) and receiving dexamethasone 10 mg at 16:00 today and 6 mg at 14:30 tomorrow, what initial NPH insulin dose should be added and how should the U‑500 regular insulin doses be adjusted?
What is the likely cause of congestion and reduced hearing in a patient without otitis media?
In a patient with bipolar disorder taking quetiapine (Seroquel) 800 mg nightly and bupropion (Wellbutrin) 150 mg each morning, what are the best options for sleep and headache management that do not have negative drug interactions?
Which ICD‑10‑CM diagnosis code should be used for a patient with dementia and behavioral disturbance characterized by severe agitation, aggression, wandering, disinhibition, and inappropriate sexual behavior?
What are the common fetal abnormalities detected on antenatal ultrasound from a pediatrician's perspective?
What is the recommended evaluation and management for a 59-year-old female with sarcoidosis, hyperlipidemia, gastroesophageal reflux disease, post‑traumatic stress disorder, pre‑diabetes, obstructive sleep apnea, recent left tympanic membrane perforation, right‑sided autophony and crackling indicating possible Eustachian tube dysfunction, recent sinus infection, right retro‑orbital photophobic headache, and chronic occipital headache?
What education should be provided to a patient with an inguinal hernia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.